Choice of first-line anaplastic lymphoma kinase (ALK) tyrosine kinase inhibitor (TKI) based on the results of a systematic review and network meta-analysis
@article{PCM7703, author = {Edyta Maria Urbanska}, title = {Choice of first-line anaplastic lymphoma kinase (ALK) tyrosine kinase inhibitor (TKI) based on the results of a systematic review and network meta-analysis}, journal = {Precision Cancer Medicine}, volume = {6}, number = {0}, year = {2023}, keywords = {}, abstract = {}, issn = {2617-2216}, url = {https://pcm.amegroups.org/article/view/7703} }